Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
08/06/2021 - 5 minutes
Kidney disease
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Update: AM-Pharma Increases Acute Kidney Injury Phase III Funds to €163M
Update (31/03/2020): AM-Pharma has raised an extra €47M on top of an existing €116M equity…
31/03/2020 - 3 minutes
Immune Marker in Blood May Predict Kidney Transplant Rejection Risk
French researchers have found that the levels of certain immune cells in the blood of…
13/03/2020 - 3 minutes
Why Communication is Key for Getting Ahead in Biotech
Many biotech founders and executives look to VC investors for advice and inspiration, but the…
18/09/2019 - 11 minutes
€43M Series C to Launch UK Company’s Home Hemodialysis Kit
Quanta Dialysis Technologies has raised €43.2M ($48M) to fund the commercial launch of a device…
29/07/2019 - 2 minutes
Update: Hansa Biopharma Applies for EMA Market Approval for Kidney Transplant Drug
Update (01/03/2019): Hansa Biopharma (previously named Hansa Medical) has filed an application for marketing authorization for imlifidase with…
01/03/2019 - 3 minutes
Genetic Testing Improves Success of Kidney Transplants
Genetic variations in cell surface proteins are able to predict kidney transplant success, shows Austrian research,…
15/02/2019 - 2 minutes
This Biotech Measures How Well Kidney Dialysis Machines Filter Your Blood
We take a hop, skip and a jump into Tallinn, Estonia this week. Optofluid Technologies…
16/11/2018 - 3 minutes
First Functioning Kidney Tissue Generated from Embryonic Stem Cells
Researchers at the University of Manchester have used embryonic stem cells to produce kidney tissue…
12/02/2018 - 3 minutes
Say Hello to a New Biotech Striving to Prevent Kidney Damage During Surgery
Balmes Transplantation has raised €700,000 in seed funding to run a proof-of-concept study to test…
06/02/2018 - 3 minutes
Update: French Biotech Closes €27M IPO to be the First to Treat Rare Disease in Children
Update (6/12/2017): Advicenne has raised a total of €27M on Euronext Paris, putting its market…
06/12/2017 - 3 minutes
Update: The First Drug for This Rare Kidney Disease May Come From a French Biotech
Update (6/11/2017): ADV7103 has maintained its efficacy in a 6-month extension of the Phase III study.…
06/11/2017 - 2 minutes
